Is human papillomavirus and p16 expression associated with survival outcomes in nasopharyngeal cancer?
- 1 November 2018
- journal article
- review article
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 39 (6) , 764-770
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK populationInfectious Agents and Cancer, 2013
- Meta-analyses: with confidence or prediction intervals?European Journal of Epidemiology, 2012
- Interpretation of random effects meta-analysesBMJ, 2011
- p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor CellsPLOS ONE, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsiesPathology, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- The Enigmatic Epidemiology of Nasopharyngeal CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2006
- Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal CancerClinical Cancer Research, 2006
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995